Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 47.4% – Here’s What Happened
by Jessica Moore · The Cerbat GemVoyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price was up 47.4% during trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Up 47.4 %
The firm has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a 50 day moving average of C$0.07 and a 200-day moving average of C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Use the MarketBeat Excel Dividend Calculator
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What Are Dividend Champions? How to Invest in the Champions
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year